Pyridine → N-(4-chlorophenyl)-1-pyrimidin-2-yl-1,2,3,6-tetrahydropyridine-4-carboxamide
反応式
[N:1]1[CH:6]=[CH:5][CH:4]=[N:3][C:2]=1[N:7]1[CH2:12][CH:11]=[C:10]([C:13]([OH:15])=O)[CH2:9][CH2:8]1.C(Cl)(C(Cl)=O)=O.N1C=CC=CC=1.[Cl:28][C:29]1[CH:35]=[CH:34][C:32]([NH2:33])=[CH:31][CH:30]=1>C(Cl)Cl.C1(C)C=CC=CC=1.CN(C1C=CN=CC=1)C.O.CN(C=O)C>[Cl:28][C:29]1[CH:35]=[CH:34][C:32]([NH:33][C:13]([C:10]2[CH2:9][CH2:8][N:7]([C:2]3[N:1]=[CH:6][CH:5]=[CH:4][N:3]=3)[CH2:12][CH:11]=2)=[O:15])=[CH:31][CH:30]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 5
実験手順
1-Pyrimidin-2-yl-1,2,3,6-tetrahydropyridine-4-carboxylic acid (55.0 mg, 0.27 mmol) and a catalytic amount of DMF were combined in CH2Cl2 (1.5 mL) and treated with (COCl)2 (0.033 mL, 0.38 mmol). The mixture was stirred for 90 minutes, diluted with toluene (0.5 mL), and concentrated to dryness under reduced pressure. The residue in CH2Cl2 (1.5 mL) was treated with pyridine (0.033 mL, 0.41 mmol), catalytic amount of DMAP, and 4-chloroaniline (41.0 mg, 0.32 mmol). The mixture was stirred for 1 hour, diluted with water, and extracted with CH2Cl2. The organic phase was dried (Na2SO4), filtered, and the filtrate was concentrated under reduced pressure. The residure was purified by flash chromatography (15% ethyl acetate/CH2Cl2) to provide the title compound. 1H NMR (300 MHz, CDCl3) δ 8.35 (d, 2H), 7.51 (d, 2H), 7.39 (brs, 1H), 7.31 (d, 2H), 6.77 (sept, 1H), 6.54 (t, 1H), 4.43 (q, 2H), 4.03 (t, 2H), 2.58 (m, 2H); MS (m/z) 315.
後処理
- concentrationconcentrated to dryness under reduced pressure
- stirringThe mixture was stirred for 1 hour
- extractionextracted with CH2Cl2
- dry with materialThe organic phase was dried (Na2SO4)
- filtrationfiltered
- concentrationthe filtrate was concentrated under reduced pressure
- customThe residure was purified by flash chromatography (15% ethyl acetate/CH2Cl2)
出典と根拠
- ORDレコード
- ord-1fa1253543254d1f9473d75cf2d81740
- 出典データセット
- uspto-grants-2006_10
- 特許番号
- US07129235B2
反応ノート
読み込み中…